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Abstract 
Sensations of dizziness or fainting (pre-syncope or syncope) on standing up from a lying 
or a seated position are usually associated with impaired blood pressure regulation 
leading to inadequate perfusion of the brain. The purpose of this project was to develop a 
simple method to provide scientists and doctors a convenient way to monitor 
cardiovascular control during orthostatic stress with the non-invasive Finometer
TM
 
device. This apparatus provides a continuous estimate of arterial blood pressure (BP) 
contour from the finger and computes brachial blood pressure contours (systolic (SBP) 
and diastolic (DBP) blood pressure), heart rate (HR), stroke volume and cardiac output 
(Q) from the Modelflow equation. In this thesis, a method was implemented to obtain an 
estimate of central venous pressure (CVP) to provide greater insight into cardiovascular 
control. The accuracy and potential errors resulting from measurement of finger arterial 
pressure were also evaluated. 
The thesis first examined whether key variables essential to monitor cardiovascular 
control can be reliably measured by the Finometer
TM
 in comparison to independent 
methods. HR was accurate and precise at rest and during stress (difference between 
methods: 0.05± 0.18 beats/min). According to standards established by the American 
Association for the Advancement of Medical Instrumentation (AAMI); at rest, DBP was 
accurate but not precise (1.6± 8.8 mmHg) and SBP was not accurate but precise (14.2± 
8.0 mmHg). These errors could be due to an improper use of our reference method. The 
post-test correction for individual characteristics proposed by the Finometer
TM
 developers 
did improve overall Q estimation (0.255± 0.441 L/min (6.9%) instead of 0.797± 0.441 
L/min (22.4%)) when compared with Doppler ultrasound but did not account for the 
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increasing error with a greater orthostatic stress induced by lower body negative pressure. 
Using finger BP instead of aortic BP to calculate Q did not explain this error as revealed 
by a new approach that compared the simultaneous pulse contours from different 
methods. Indeed, there was no significant difference between the error of the estimation 
of Q from the finger arterial pulse compared to the estimation of Q from the independent 
measurement by tonometry on the brachial artery at rest (-1.13± 14.67%) and at the 
maximum orthostatic stress used (-0.61± 9.33%) (p>0.05). Using brachial BP to calculate 
Q did not improve the result found with finger BP. 
The first hypothesis of this thesis that CVP could be estimated from outputs of the 
Finometer
TM
 compared to direct venous pressure measurement was supported for the 
individual (0.2± 1.7 mmHg) and test specific (0.1± 1.2 mmHg) equations. The general 
equations derived from group data were accurate but not precise enough (0.4± 2.8 
mmHg) to be used in clinical and research setting. The success of the individual equations 
suggests that it might be possible to derive a personal equation that will be useful over a 
long period for similar tests by using a catheter only once. The second and third 
hypotheses related to the cause of discrepancy between Q from FinometerTM and Q from 
Doppler, were not supported by the data. However, a new contour analysis method 
introduced here in a graphical format might provide an opportunity for systematic 
analyses of the deviation between methods. It could reveal sources of error allowing 
future improvements in the accuracy and precision of Q from Finometer
TM
 during 
orthostatic or physical stress. 
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Every year, thousands of people faint (syncope) or experience dizziness, light headedness 
or blurred vision that might be symptoms of pre-syncope after standing from a lying or a 
seated position. Orthostatic hypotension, defined by a drop >20 mmHg systolic blood 
pressure or >10 mmHg diastolic blood pressure within 3 minutes of standing [Low, 2008] 
is often associated with these symptoms. An integrated cardiovascular control response is 
initiated on moving to a head up posture to counterbalance the footward blood shift 
induced by the gravity vector and a slow or inappropriate reaction of these mechanisms 
could lead to an inadequate perfusion of the brain and to a fainting episode. In the elderly 
population for example, the incidence of orthostatic hypotension might reach as high as 
30% with important increased risk of mortality associated with this impaired blood 
pressure regulation [Low, 2008]. 
The aim of this project is to develop a simple, non-invasive method that will provide 
scientists and doctors a way to monitor cardiovascular control during orthostatic stress to 
enable isolation of the specific factors that might cause fainting in different individuals. 
This kind of method has a lot of potential to provide a first evaluation of important 
clinical signs (blood pressure, stroke volume, heart rate, etc.) that might require detailed 
investigations. This can also be convenient in research setting for situations in which 
there is a restriction on using more elaborate and specific equipments due to the location 
(such as on the International Space Station) or the type of research. 
The Finometer device for non-invasive estimates of arterial blood pressure is already well 
known and implemented in clinical and research laboratories. This innovative machine 
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based on the volume-clamp method [Peñáz et al., 1973] measures continuous non-
invasive finger arterial pressure and estimates several variables that can be used in the 
investigation of the cardiovascular control mechanisms. Although this device has a lot of 
potential for our purpose, many groups are concerned about its accuracy [Hirschl et al., 
1997; Remmen et al., 2002; Azabji Kenfack et al., 2004]. Indeed, a growing body of 
scientific research shows that the Finometer calibration is quite complex and that it might 
change depending on the subject and the stress applied [Houtman et al., 1999; Azabji 
Kenfack et al., 2004; Stok et al., 2006]. This is a concern for us as we are looking for a 
device that can be applied under conditions of changing postural stress. 
In order to cover the first steps of the development of a method, my thesis is separated in 
two different projects covering three steps. In the first project, we will examine whether 
key variables essential to monitor cardiovascular control can be reliably measured and 
calculated by the Finometer in comparison to independent methods. For the second 
project, we will investigate further what are the causes of the Finometer’s limitations and 
propose solutions to increase its accuracy. 
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2. Literature Review 
2.1- Orthostatic Stress 
Every human experiences orthostatic stress in his/her daily life during changes in posture 
from lying in bed to sitting or standing up. Although these activities seem very simple, 
changes in the posture will create perturbations of the homeostasis that without 
appropriate reflex actions of the cardiovascular system would result in fainting. 
When a person moves to an upright position 70% to 75% of his/her blood volume is 
below heart level [Rowell, 1993]. The force of gravity induces this blood downshift and 
contributes to increase the pressure in the lower limbs (figure 1). The position of the brain 
above the heart makes it very susceptible to ischemia and challenges the human body to 
properly perfuse it [Rowell, 1993]. 
 
Figure 1: Distribution of vascular pressures in supine and upright human 
[from Rowell, 1993] 
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Although gravity has a big effect on the human blood circulation, individuals are able to 
move to and keep an upright posture with the help of different regulatory mechanisms 
that work to maintain sufficient arterial blood pressure to drive blood to the brain. 
2.2- Cardiovascular Control in Response to Orthostatic Stress 
The cardiovascular control centre (CCC) located in the medulla is responsible for the 
challenge of maintaining blood pressure to preserve brain blood flow during orthostatic 
stress. It works in a closed-loop system and controls mechanisms operating on the 
peripheral resistance and the cardiac output to regulate arterial blood pressure. This 
relationship is expressed in a form of Ohm’s law for the circulation relating the pressure 
gradient (∆P) from ejection of blood into the aorta to return to the right atrium as a 
function of cardiac output and resistance to flow: 
 TPRQCVPMAPP ×=−=∆ &  (Eq 1) 
Where MAP is mean arterial blood pressure [mmHg], CVP is central venous pressure 
[mmHg], Q&  is cardiac output [L/min] and TPR is total peripheral resistance 
[mmHg/L/min]. The formulation in equation 1 is utilized to represent the whole body 
reaction to a stress. 
The cardiovascular control centre (CCC) receives afferent information about change in 
pressure from baroreceptors located in the arterial system in the aorta and the carotid 
sinuses (arterial baroreceptors) and in the low pressure venous side of the heart in the 
inner wall of the right atrium and the pulmonary arteries (cardiopulmonary 
baroreceptors). Any record of a change will activate the autonomic nervous system which 
will send efferent signals to adjust flow and peripheral resistance in order to correct the 
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situation toward the stability of a steady state. As explained in section 2.1, moving into an 
upright posture will initiate a downward shift of blood volume and decrease blood 
pressure above the level of the heart. This situation will decrease the firing rate of the 
different baroreceptors and send the signal to increase total peripheral resistance (TPR) 
and Q via the CCC. These changes are made through different pathways. Indeed, TPR 
will be increased via the sympathetic system releasing more norepinephrine causing 
primarily arteriolar vasoconstriction. The increase in cardiac output is driven primarily by 
an initial increase in heart rate (HR) due to parasympathetic nervous system withdrawal, 
as well as potential increases in sympathetic nervous system activity to further increase 
HR and cardiac stroke volume (SV) [Silverthorn, 2007]. 
The clinical relevance to record blood pressure (BP), CVP, TPR, Q, SV and HR is then 
very significant for doctors and scientists investigating cardiovascular control. Any kind 
of stress will create variation in these variables and will be unique as the proportion and 
the amplitude of the reactions will differ. 
CVP and arterial blood pressure are key cardiovascular variables that act as inputs to the 
cardiopulmonary baroreceptors and the arterial baroreceptors respectively. The 
cardiopulmonary baroreceptors are primarily responsible for regulation of TPR operating 
in a feed forward manner to reflect changes in venous return. The arterial baroreceptors 
can affect HR, cardiac contractility and TPR. In this system, a reduction in CVP is a good 
indicator that blood is pooling in the vascular tree during an upright posture as it will 
decrease almost instantaneously with the diminution of blood going back to the heart 
[Rowell, 1993]. 
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The ability to follow changes in TPR provides a valuable indicator of mechanisms 
working to regulate blood distribution through neural and local mechanisms. The 
hormonal, myogenic, metabolic and endothelium-mediated vascular control mechanisms 
are all working locally to change peripheral resistance by amplifying or diminishing the 
efferent signal sent via the sympathetic nervous system. Although investigation of the 
specific involvement of these peripheral factors during a stress requires additional 
techniques such as a blood sample, their general effect is included in TPR. 
2.3- Heart Performances in Response to Orthostatic Stress 
Standing from a lying or a seated position reduces the quantity of blood coming back to 
the heart. Since the heart can only pump the blood received, SV will be reduced by 
approximately 40% in an upright posture [Poliner et al., 1980; Rowell, 1986; Rowell, 
1993] 
Interestingly, an increase in blood volume coming into the heart will also increase its SV. 
This is explained by the Frank-Starling mechanism, which refers to the length-tension 
relationship of the myocardial muscle fibres. Indeed, contraction force increases when 
sarcomere length increases up to an optimal length. This means that an increase of the left 




Figure 2: Length-force relationships in the intact heart: a Starling curve 
[from Silverthorn, 2007] 
In a preliminary study, we demonstrated a linear relationship between CVP and SV using 
a lower body negative pressure (LBNP) device to simulate gravity in subjects before and 
after a 4h hour head down tilted bed rest [Gagné et al., 2007]. We reasoned that this 
relationship followed the Frank-Starling mechanism with CVP as an indicator of the 
preload of the heart. Further investigations of those preliminary data have shown that this 
relationship is specific to every subject. 
The ejection fraction (EF) is the ratio of blood ejected by the heart relative to the left 
ventricular end-diastolic volume (LVEDV). EF is very important to take into account 
when assessing heart performance because it depends mainly on the left ventricular 
contractility. The Frank-Starling mechanism becomes then very specific to every single 
heart and is influenced by inotropic agents, aging [Fleg, 1986] and prolonged bed rest 
[Levine et al., 1997]. The residual pressure in the aorta (DBP) can also influence EF 
throughout a stress. Indeed, an increase in the afterload of the heart will reduce SV and 
this will in turn result in an increase in LVEDV [Nevo, 1993]. 
Although the heart’s performance is dependent on its mechanics, it is also influenced by 
the cardiovascular control of the arterial tree. As explained in section 2.2, to maintain 
 8 
blood pressure in order to preserve brain blood flow, the CNS is actively controlling the 
heart rate and cardiac contractility through efferent signals. In addition, blood volume, 
venous compliance, MAP, Q and TPR are all variables that will influence the quantity of 
blood available to pump by the heart. For these reasons, it is generally accepted that the 
performance of the heart is determined primarily by the peripheral circulation [Rowell, 
1993]. 
2.4- Blood Pressure Waveform during Orthostatic Stress 
The blood pressure waveform can be described by four elements: the peak of the 
waveform called systolic blood pressure (SBP), the minimum of the waveform called 
diastolic blood pressure (DBP), the mean of those two values called mean arterial 
pressure (MAP) and finally, the difference between SBP and DBP called pulsed pressure 
(PP). Within the arterial tree, blood pressure is influenced by three different components: 
the static pressure, the dynamic pressure and the hydrostatic pressure. The first one refers 
to pressure created by a volume of blood pushing on the arterial wall when there is no 
flow. The second one refers to the pressure created by a flow pushing in resistance artery. 
Finally, the third one is caused by the force of gravity on a column of blood [Rowell, 
1993]. These three components are in part responsible for the magnitude and the shape of 
the pressure contour. 
The arterial BP waveform is not the same in the aorta as it is in the peripheral arteries. In 
fact, the transmission of the pressure along the arterial tree is distorted by both pressure 
gradient and a reflected wave [Bos et al., 1996]. The addition of the forwarded wave and 
the forepart of a wave returning from a reflecting end of the arterial tree will define the 
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pressure contour depending of the position of the artery investigated [Remington and 
Wood, 1956]. 
 
Figure 3: Transformation of pulse starting from aorta and passing in the subclavian-arm 
system [from Remington and Wood, 1956] 
Although MAP is smaller in the peripheral arteries; the pulse pressure increases, the 
systolic peak pressure is narrowed and progressively delayed to account for the 
propagation of the wave [Remington and Wood, 1956]. 
At rest, the pressure waveform difference between central and peripheral arteries will 
change from person to person due to individual characteristics such as increased arterial 
wall stiffness as seen with aging [O’Rourke, 2005]. This is indicated by studies showing 
that an individual transfer function provides better prediction of central BP waveform 
than a general transfer function developed from a large population [Segers et al., 2000; 
Karamanoglu et al., 1997]. These transfer functions mathematically represent BP change 
in the frequency domain between a central and a peripheral artery. 
Orthostatic stress will influence the difference between central and peripheral pressure 
contour. The increased sympathetic activity occurring while moving in an upright posture 
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will cause greater change in the peripheral vessels than in the aorta [Houtman et al., 
1999]. This will affect the pressure waveform by increasing the speed at which the 
reflected wave will move back [Westerhof and O’Rourke, 1995; Stok et al., 2006] and 
change the transfer function of central over peripheral pressure. Stok and colleagues 
(2006) have shown the same idea, but using exercise as a stress. 
2.5- Non-Invasive Instrument: the FinometerTM 
The Finometer is a non-invasive instrument and the successor of the Finapres used in 
both ambulatory clinics and laboratories all around the world. It is mainly utilized to 
measure the equivalent of brachial blood pressure (brachial BP) from the finger blood 
pressure (finger BP) and can also provide estimates of stroke volume (SV) and cardiac 
output (Q). 
The Finometer, as presented in figure 4, monitors hemodynamic events by using three 




Figure 4: Schematic Representation of the FinometerTM Layout 
2.5.1- Monitoring Finger Blood Pressure 
Finger blood pressure is measured with a cuff wrapped around the finger (shown in figure 
5-A) and following the volume-clamp method developed by Juan Peñáz [Peñáz, 1973]. 
The principle of this method is to dynamically keep constant the finger arterial diameter 
at a predefined set-point with the help of a pneumatic servo-system [Wesseling et al., 
1995]. The set-point used is defined by an algorithm (Physiocal) that is searching for the 
“unloaded” diameter [Wesseling et al., 1995]. This particular diameter is established 
when the transmural pressure of the arterial wall is zero; meaning that the pressure inside 
is equal to the pressure outside the artery. Therefore, the pressure delivered by the servo-
controller to the finger cuff in order to keep constant the artery diameter will also be the 
finger blood pressure. 
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Changes in hematocrit, stress and the tone of smooth muscle in the arterial wall will 
affect the unloaded diameter [FMS website]. The Physiocal algorithm will then 
recalibrate the unloaded diameter after a set number of heart beats. The changes in 
diameter are sent to the servo-controller by an infrared photo-plethysmograph placed in 
the finger cuff [Boehmer et al., 1987]. 
 
Figure 5: A) Finger Cuff; B) Finger Cross-Section [Modified from FMS website] 
From this step, the Finometer can accurately estimate the heart rate (HR) from the servo-
controller as a new waveform recorded means a new heart beat. 
2.5.2- Estimation of Brachial Blood Pressure 
As explained in section 2.4, pressure waveforms change while going from brachial to 
finger arteries. An inverse modelling correction and a height corrector are then used to 
reconstruct the brachial blood pressure from the finger blood pressure. 
The inverse modelling correction is actually a frequency-dependent transfer function used 
as a filter [Bos et al., 1996]. The transfer function from brachial to finger blood pressure 
has been developed by Gizdulich and colleagues and published in 1997. It has been 
shown to resonate (oscillate at a maximum amplitude) at a frequency ranging from 
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4.26Hz to 10.58Hz depending of the subject [Gizdulich et al., 1997] and causes a 
distortion. Since the mean value is approximately 8Hz, the Finometer’s designers have 
used a frequency-dependent filter with an anti-resonance frequency of 8Hz to neutralize 
this distortion [FMS website]. 
 
Figure 6: A) Transfer Function Amplitude Comparison; B) Reconstruction of brachial 
blood pressure (gray line) from the finger blood pressure (black line) [from FMS website] 
Figure 6-A, taken from the FMS website, shows the transfer function amplitude (top 
line), the frequency-dependent filter amplitude (bottom line) and the expected result of 
the overall transfer function amplitude (middle line) of one subject [FMS website]. It is 
important that this overall transfer function amplitude stay as close as possible to 1. A 
deviation from this will give an amplification or an attenuation of the signal at a 
particular frequency and will be seen as a distortion. The use of a fixed anti-resonance 
frequency is then good in the case where almost all subjects have their transfer function 
resonating at around 8Hz, but will create discrepancies in case of subjects having their 
transfer function resonating at 5 Hz for example. 
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In the case of an average person, figure 6-A demonstrates that the inverse model will 
contribute to change a little bit the shape of the brachial blood pressure in the low 
frequencies but will have a bigger influence in the high frequencies. This means that the 
shape of the systolic portion will be the most influenced [Bos et al., 1996] as shown in 
the top and the middle panel of figure 6-B. 
A height corrector is also needed to counterbalance the pressure gradient driving the flow 
from the brachial artery to the finger artery. As explained previously in section 2.1, the 
hydrostatic pressure will play a role in the pressure gradient and should be taken into 
account by using two sensors for the finger and the brachial level. The bottom panel of 
figure 6-B shows its effect. 
The return-to-flow calibration is done by an upper-arm cuff following the idea of a 
standard sphygmomanometer. The upper-arm cuff positioned on the same arm as the 
finger cuff will completely stop the flow through the brachial artery if its pressure is 
higher than the systolic blood pressure (SBP). The pressure is then decreased until it 
reaches the systolic blood pressure and allows the first pulsation that will be sensed and 
recorded by the finger cuff [FMS website]. This method is used to calibrate the systolic 
blood pressure and then reach the American Association for the Advancement of Medical 
Instrumentation (AAMI) standard (bias should be less than ± 5mmHg and precision 
should be better than ± 8mmHg [Finometer
TM
 User’s Guide]). 
The estimation of brachial blood pressure waveform allows the Finometer to estimate the 
mean arterial pressure (MAP), the systolic blood pressure (SBP), the diastolic blood 
pressure (DBP) and the pulse pressure (PP). 
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2.5.3- Estimation of Stroke Volume and Cardiac Output 
Stroke Volume and Cardiac output are estimated from finger arterial blood pressure with 
the help of the Langwouters’ equation and the Modelflow method. As shown in figure 7-
B, the Modelflow method is a non-linear three elements model of the aortic input 
impedance developed by Wesseling and colleagues in 1993. The model elements 
represent aortic characteristic impedance (Z0), Windkessel arterial compliance (CW) and 
systemic vascular resistance (RP) [Wesseling et al., 1993]. 
 
Figure 7: A) Pressure waveform; B) Modelflow model; C) Aortic flow waveform 
[from FMS website] 
The aortic characteristic impedance element (Z0) represents the aortic opposition to the 
pulsatile flow from the contracting left ventricle while the Windkessel arterial 
compliance element (CW) refers to the aortic elastic storing property and the opposition to 
an increase in blood volume [Wesseling et al., 1993; Harms et al., 1999]. Both elements 
are pressure-dependent because the elastic behaviour of the aorta varies non-linearly with 
the changing pressure [Langwouters et al., 1985; Bogert et al., 2005]. Their parameter 
values are then computed with the help of an algorithm to calculate the aortic diameter 























 (Eq 2) 
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Where Amax is a parameter based on the sex of the subject while p0 and p1 are parameters 
based on the age and the sex of the subject. 
The systemic vascular resistance element (RP) refers to the Poiseuille resistance of all 
vascular beds together. It is a measure of the ease of constant blood drainage from the 
Windkessel into the peripheral vascular beds [Wesseling et al., 1993] [Harms et al., 
1999]. 
The modelflow method will estimate the aortic flow waveform from the finger arterial 
blood pressure waveform (see figure 7). Stroke volume (SV) and cardiac output (Q) will 
then be calculated from the shape of the aortic waveform. Indeed, the integral (area under 
the curve) of the waveform will give SV, and Q can be determined by the equation 3: 
 HRSVQ ×=&  (Eq 3) 
According to Wesseling and colleagues (1993), the peripheral resistance (PR) at the level 
of the aorta will be calculated as the sum of the aortic resistance to the pulsatile flow 
(aortic characteristic impedance - Z0) and the resistance coming from the vascular beds 
(systemic vascular resistance - RP). This is the equivalent of stating that CVP is equal to 
zero. Although it is not physiologic, removing a small number from the Ohm’s equation 




RZPR P =+= 0  (Eq 4) 
2.5.4- Concerns about the Accuracy of the FinometerTM 
Concepts used in the Finometer are the result of a long development process, but it still 
does not give perfect values. The main problem resides in the non-invasive aspect of the 
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Finometer. As pointed out in the Finometer
TM
 User’s Guide: “non-invasive methods are 
usually associated with reduced accuracy” given that the variables are not directly 
measured. Although this innovative device has a lot of potential, the next section reveals 
a growing body of scientific research that suggests borderline accuracy in regard to the 
AAMI standard and in comparison with the “gold standard”. 
Monitoring Finger Blood Pressure 
Under normal condition and moderate vasoconstriction, the Finometer is known to give 
similar finger BP response when compared to other methods of arterial BP measurement 
[Wesseling et al., 1985; Jagomägi et al., 1996; Raamat et al., 2006]. However, intensive 
vasoconstriction, as might be observed during cold exposure or activities in which 
sympathetic neural activity is elevated, decreases the accuracy of the finger BP 
measurement [Wesseling et al., 1985; Raamat et al., 2000; Jagomägi et al., 2001]. 
As mentioned in the Finometer
TM
 User’s Guide, some situations cannot be accurately 
monitored by finger volume-clamp method. Indeed, higher BP in an artery would stretch 
the vessel wall closer to its maximal capacity. An increase in BP in such a vessel would 
then not change its cross-section as much as an unstressed vessel wall which is more 
compliant. For the same reason, in vessels that become stiffer due to other factors (aging, 
hypertension) the cross-section would not change as much as a more compliant one 
[Langewouters et al., 1986]. The non-linearity of the pressure-diameter relationship can 
cause the servo-controller to be less accurate in the extreme conditions. 
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Since finger BP measurements are assumed to be accurate under normal condition, the 
attention of researchers is turned to the estimation of brachial BP, SV and Q from the 
finger BP to find the source of the discrepancy problem. 
Estimation of Brachial Blood Pressure 
According to the Finometer
TM
 User’s Guide, the bias and the precision between Finger 
BP and Brachial BP before and after the full-calibration procedure are as follows: 
Table 1: Bias and Precision in Brachial BP [FinometerTM User’s Guide] 
Level Pre-Calibration 
(Finger BP-Brachial BP) 
Post-Calibration 
(Reconstructed Brachial BP-Brachial BP) 
SBP +1 ±11 mmHg +4 ±7 mmHg 
DBP -8 ±8 mmHg +1 ±5 mmHg 
MAP -10 ±7 mmHg +1 ±5 mmHg 
Considering that AAMI standard requires bias to be less than ± 5mmHg and precision to 
be better than ± 8mmHg [Finometer
TM
 User’s Guide], the post-calibration data are 
considered sufficiently accurate and precise. 
A recent study from Guelen and colleagues (2008) has shown the importance of the 
different calibration: 
Table 2: Bias and Precision between Finger BP and Brachial BP [Guelen et al., 2008] 
Level Before 
Calibration 
After Waveform Filtering and 
Level Correction Calibration 
After RTF 
Calibration 
SBP -10 ±13 mmHg -1 ±11 mmHg 3 ±8 mmHg 
DBP -12 ±8 mmHg 0 ±7 mmHg 4 ±6 mmHg 
MAP -16 ±8 mmHg -2 ±7 mmHg 3 ±5 mmHg 
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Many datasets could have been presented here to illustrate the behaviour of the 
reconstructed brachial BP at rest, but they all conclude the same thing. To estimate 
brachial BP properly, the finger BP should be calibrated for the pulse shape difference 
and the pressure gradient between the finger and the brachial artery. Interestingly, it is 
also possible to see that SBP has a larger error than the two others but still stays within 
the AAMI standard. 
Similar results are observed during stress. DBP and MAP of the finger BP could be good 
indicator of brachial BP, but SBP is overestimated over the AAMI standard [Idema et al., 
1989; Imholz et al., 1990]. The reconstructed brachial BP from finger BP is 
recommended and proven to account for the bias during orthostatic stress [Bogert et al., 
2004]. 
The distortion of the pulse waveform while passing from compliant to stiffer arteries is 
the cause of the discrepancy between finger BP and brachial BP. On the other hand, the 
offset of SBP compared to DBP and MAP after waveform filtering and level correction 
might be due to the generalised transfer function used in the inverse model. Gizdulich 
and colleagues (1997) have shown that their transfer function resonates at a frequency 
ranging from 4.26Hz to 10.58Hz depending of the subject’s individual characteristics. 
Even though this range is quite large, they applied a filter with a fixed anti-resonance 
frequency of 8Hz. This would lead to a bad neutralisation of the distortion in the high 




Estimations of Stroke Volume and Cardiac Output 
Many studies have shown the inaccuracy of SV and Q Modelflow estimations from 
finger blood pressure [Hirschl et al., 1997; Remmen et al., 2002; Azabji Kenfack et al., 
2004]. Calibrations against a “gold standard” like thermodilution [Jansen et al., 2001] or 
Fick’s equation [van Lieshout et al., 2001(a)] is required in order to get absolute values. 
These calibrations are done to take into account individual characteristics changing the 
pressure-area relationship of the aorta [FinometerTM User’s Guide]. This relation 
(Langewouters’ algorithm) estimates aorta diameter from a study that investigated the 
static properties of post-mortem aorta [Langewouters et al., 1984]. The biggest problem 
comes from the aortic diameter at maximal pressure which is only dependent on gender 
and may vary up to ±40% from the population average [van Lieshout and Wesseling, 
2001]. 
According to the FinometerTM User’s Guide, the bias and the precision of Q before and 
after the calibration procedure are as follows: 
Table 3: Bias and Precision between FinometerTM and Thermodilution Q 
[Finometer
TM
 User’s Guide, 2003] 
 Bias Precision 
Pre-Calibration +0.3 L/min 1.0 L/min (20%) 
Post-Calibration -0.1 L/min 0.5 L/min (8%) 
According to table 3, the Modelflow method implemented in the Finometer can 
accurately measure Q at rest with the same precision as thermodilution. Jellema and 
colleagues (1999) have shown that once calibrated, the Modelflow model will keep track 
of Q even after 48h in ICU patient undergoing septic shock. If not calibrated, the values 
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recorded by the Finometer would then represent only the variations of Q [Harms et al., 
1999]. 
If a stress occurs, the accuracy of the Finometer’s estimation of SV and Q is questionable 
even though it has been previously calibrated. In fact, some researchers have indicated a 
decrease in accuracy during exercise [Houtman et al., 1999; Azabji Kenfack et al., 2004] 
and passive head-up tilt [van Lieshout et al., 2003] while others have shown it to be 
accurate during postural stress [Harms et al., 1999; Matsukawa et al., 2004] and exercise 
[Matsukawa et al., 2004]. Recently, unpublished research from our lab has shown that the 
discrepancy in SV increased with an increasing change in TPR [Dyson et al., 
unpublished] 
The causes of the borderline accuracy during a stress are related to the accumulation of 
error from the three estimations changing finger BP waveform into Q waveform: using 
finger BP waveform to represent aorta BP waveform, the Langewouters’ algorithm and 
the Modelflow method. 
As explained in section 2.4, finger BP differs in shape and magnitude from aortic BP. 
This difference would become even more significant with a stress because TPR would 
increase PWV and so, change the shape of the pressure contour in both arteries but not in 
the same manner. The limitations coming from the Langewouters’ algorithm during a 
stress and after an initial calibration at rest are very small. For example, an increased 
tonus of the aortic wall smooth muscle will decrease the maximal aortic diameter and 
decrease compliance for a given pressure [Heerman et al., 2005]. This will create an error 
in the calculation of SV and Q because these variables are represented by parameters 
fixed in the model with the age and the gender of the person [Wesseling et al., 1993]. The 
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Modelflow model can fit experimental data well and can produce realistic Q waveform 
[Stergiopulos et al., 1999]. But it is still a source of error considering that the three-
element model is a representation of vascular properties. To improve this, it has been 
shown that the addition of the inertia of the whole arterial tree as a fourth element to take 
into account the very low frequency of the arterial BP may provide more accurate results 
[Stergiopulos et al., 1999]. 
Considering this accumulation of error, the easiest way to calibrate the estimation of SV 
and Q is to create a calibration factor against a “gold standard”. This technique could 
work with well monitored studies but it is not favourable when the Finometer is the only 
instrument used. It is also challenging because every subject will need a different 
calibration factor at rest and potentially at every stage of a stress. 
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3. Hypotheses 
To develop a method, several important steps should be taken into account. Figure 8 is a 
schematic representation of these steps: 
 
Figure 8: Flow chart of the different steps of the development of the method 
The first hypothesis is addressed within Project 1 and the second and the third hypotheses 
within Project 2. 
First of all, we decided to use the Finometer as our non-invasive instrument because it is 
a well recognised machine used in both research and clinical environments. It also 
measures and estimates almost all the variables of the cardiovascular control 
mechanisms. 
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Second, even though the Finometer is providing almost all the variables essential to 
monitor the cardiovascular control mechanisms, two of them are missing: TPR and CVP. 
Our first project is to create a relation providing these variables with the actual setup of 
the Finometer and all the tools given to us to calibrate it. 
Finally, more and more articles are published about the Finometer’s “borderline” 
accuracy of Q in comparison to a “gold standard”. The development of a method to get 
all the information needed from the Finometer would then be more valuable if the 
machine is reaching higher data quality standard. For our second project, we will be 
looking at the possible causes of the Finometer’s limitations in order to propose solutions 
to increase its ability to measure Q accurately and precisely. 
3.1- Development of the Relation 
3.1.1- Initial Calibration of Cardiac Output 
As shown in section 2.5.4, the Finometer’s designers recognise the need of an initial 
calibration. They attribute this to an estimation of the aorta diameter made from the 
Langwouter’s algorithm which is using only the age and the gender of the subject. To 
improve the quality of the measurements they add on the possibility to correct the aorta 
diameter estimated from the Finometer against another method. This technique has been 
proven possible on patients with coronary artery bypass graft and/or valve replacement 
[de Vaal et al., 2005] and so we will be using it for our purpose with the help of an echo 
ultrasound device. 
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3.1.2- Relation Between all the Variables 
Most of the variables are already estimated by the Finometer. HR is estimated directly by 
the detection of a new waveform from the servo-controller, BP is estimated from the 
inverse model and Q is a direct output of the Modelflow method. CVP and TPR have to 
be found or mathematically extracted. 
Our two missing variables are linked together by the physiology version of the Ohm’s 






=  (Recall of Eq. 1) 
Although CVP can be measured with a catheter, TPR is the only variable of this formula 
that cannot be recorded with precision. Indeed, as explained in section 2.2, TPR regroups 
all the mechanisms working to control blood distribution. The only technique to get a 
good approximation of all their effects together is through this formula. Our search for 
the two missing variables should then start with CVP. 
Looking at the heart as a system is probably the best approach to eliminate TPR from the 
relation while still including its effect. As explained in section 2.3, TPR per se is not a 
direct input or output of the heart but does influence its performance by playing on the 
quantity of blood available to pump [Rowell et al., 1993]. 
According to the results of Gagné and colleagues (2007) and the further investigations 
described in section 2.3, we first hypothesize that estimations of CVP derived from a 
modified Frank-Starling mechanism relationship would be accurate and reliable 
compared to CVP measured with a catheter. To cover the individual characteristics 
responsible to modify the Frank-Starling mechanism, we will include the EF measured 
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previously at rest from an echo ultrasound device. DBP will be included in the relation to 
account for the changes in afterload throughout the test. This will allow a calculation of 
LVEDV from SV at rest and during different stages of orthostatic stress. Since LVEDV 
is influenced by the preload (CVP) and the filling time of the heart (HR), a multiple 
linear regression will be applied. 
Creating a relation to find CVP from SV, HR and DBP will be very convenient since they 
are all outputs of the Finometer. EF measurement, also needed in our relation, is not out 
of reach since the calibration of the Finometer already requires the use of an echo 
ultrasound device to fix the aorta diameter. Furthermore, including HR and DBP in the 
equation is also a manner to take into account the activity of the CNS. 
3.2- Investigation of Cardiac Output Measurement 
As shown in section 2.5.4, many articles are published about the dubious accuracy of Q 
and SV estimated by the Finometer in comparison to a “gold standard”. The Finometer is 
very good at tracking variation at rest once calibrated, but when a stress is applied, an 
error could appear. This error seems to depend on the type of the stress and might vary 
with TPR [Dyson et al., unpublished], although recent observations of Modelflow 
estimation of Q during exercise revealed no bias across a wide range of work rates 
relative to acetylene rebreathing [Faisal et al., In press]. 
An examination of the process reveals three possible different sources of error in the 
estimation of Q and SV: using finger BP as a representation of aortic BP, the 
Langewouters’ algorithm and the Modelflow model. Considering that a change in TPR 
will have a direct effect on the pulse contour of peripheral arteries compared to the main 
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conduit artery, we thought that the first one will have the greatest impact on the 
estimation of Q and SV during change in TPR. Our primary objective here was to verify 
whether or not using finger BP as a representation of aortic BP can lead to an error in the 
estimation of Q and SV during a stress. In the case that it does play a role in the 
discrepancy, our second objective was to determine whether or not using finger BP to 
represent aortic BP is the major source of error. In order to reach these two (2) objectives, 
the second hypothesis was that the estimation made by using finger BP to represent 
aortic BP would account for more than 50% of the error in the estimation of Q and 
SV during a change in TPR. 
Although we are fully aware that estimations will never give perfect values, the 
borderline accuracy of Q and SV during a stress may introduce an important error in 
clinical and research environments. As a follow up to the previous hypothesis and in an 
effort to reach a precision equivalent to the thermodilution reference technique, the third 
hypothesis was that Q and SV error can be reduced to 8% throughout a stress by 
using the reconstructed brachial BP as an input to the Modelflow model. 
Considering that a growing body of research has shown reconstructed brachial BP to be 
accurate and within the AAMI standard at rest and during exercise, this variable could be 
a useful tool since it is already calculated by the Finometer
TM
 and would account for 
different stress. 
To achieves all these objectives, it was determined that an alternative approach was 
required in this study because of a difficulty in solving Modelflow. Thus, the contours of 
finger BP and the reconstructed brachial BP were compared with a reference brachial BP 
obtained with the Millar pressure transducer in order to get information about 
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overestimation and underestimation of Q from the different methods. It is important to 
note here that this approach only allowed conclusion about the primary objective of 
hypothesis 2 and the general objective of hypothesis 3. No definitive conclusion can be 
made about these two hypotheses with the study of pulse wave contours as opposed to 
direct calculation of Q with Modelflow. 
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4. Methodology 
To investigate the hypotheses above, two protocols were used. 
The first protocol was included in a big project serving three Master’s theses and one 
PhD thesis. The experiment design has been constructed by the team to investigate the 
value of fluid loading procedure given to astronauts before their return to Earth in order 
to maintain cardiovascular responses with the reapplication of orthostatic stress. Some of 
the steps in the data collection might seem not related to my own thesis but are very 
important for others. 
The second protocol was a prolongation of the first protocol as it used a similar 
population and a similar stress. The variables measured are those that were impossible to 
evaluate on the previous protocol without affecting other variables important to my 
teammates. 
The study was approved by the Office of Human Research Ethics at University of 
Waterloo. 
4.1- Experimental Design 
4.1.1- Participants 
Twelve healthy young males between the ages of 18 to 33 years old participated in this 
project. Eight of them took part of the first project. Four of them came back and took part 
of the second project along with four new subjects. 
Prior to the first test in the lab, the subjects signed an informed consent form to confirm 
that they have read and received explanations of a list of risks related to the test. They 
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received money for their participation in the study and had the right to withdraw at 
anytime during the experiment. 
4.1.2- First Project 
The project required every subject to come five (5) times in the lab for five (5) different 
tests: 
A) 4h seated without fluid loading D) 28h bed rest without fluid loading 
B) 4h seated with fluid loading E) 28h bed rest with fluid loading 
C) 4h bed rest without fluid loading 
Contrary to my colleagues, I am not looking at the effect of bed rest and fluid loading on 
the human body. Consequently, I am only using the dataset from the first LBNP protocol 
of every test. 
Pre-Test Preparation 
Subjects were asked to avoid alcohol and caffeine for twenty-four (24) hours prior to the 
test. They were also asked to keep up to date a food diary starting three days before the 
test in order to control their sodium intake which should not be more than approximately 
2000mg/day. They were also asked to drink 5mL of water per kilogram of body mass the 
night before the test and the morning of the test to promote proper hydration. 
Every subject was asked to come in the lab at 7am after an 8h sleep and a small breakfast 
taken at 6am. We measured height and weight and a certified lab technician inserted a 22 
gauge catheter (BD Insyte, BD Medical Systems, Sandy, USA) in the mean cubital vein of 
the right arm for drawing blood samples and measuring CVP. 
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Lower Body Negative Pressure (LBNP) 
To challenge the cardiovascular control of the human body we simulated orthostatic 
stress with a lower body negative pressure (LBNP) device. It was a home-made sealed 
wooden box linked to a vacuum (Beau•mark 99056). The level of suction was controlled 
with a rheostat (Staco Inc, Dayton, Ohio) connected to the vacuum and an electronic 
pressure gauge (Traceable ®) hooked directly to the box. 
Subject were asked to lie down with their lower body placed in the LBNP box and the 
area around their waist sealed with a neoprene skirt. They were reminded of the moderate 
risks to experience dizziness during the suction and were asked to inform the 
investigators if these symptoms occurred. In such a case, the suction pressure was 
immediately removed and the symptoms disappeared very quickly since blood was 
rapidly returned to the heart and the brain. To avoid a fainting episode, the protocol was 
stopped if the systolic blood pressure (SBP) was less than 80mmHg or the heart rate (HR) 
or the blood pressure (BP) dropped quickly. 
The LBNP protocol as presented in figure 9 occurred at approximately 9am for every test 
to take into account the circadian cycle. We used a constant decrease of pressure protocol 




Figure 9: LBNP protocol of the first project 
Cardiac Measurement 
Cardiac measurements were taken in the baseline period before the start of LBNP and at 
the end of the LBNP session by first rotating the subject from right-side down (required 
for CVP measurement) to left-side down (optimizing the ultrasound window to image the 
heart) then reapplying the -40 mmHg LBNP for an additional 2-minutes with an echo 
ultrasound device (MicroMaxx, Sonosite Inc, Bothell WA, USA) and a 1-5MHz 
transducer probe (P17, Sonosite Inc, Bothell WA, USA). The tilt movement was easily 
accomplished as the entire LBNP box is on three (3) sets of pillow blocks fixed to a table. 
The diameter of the aorta was taken at the sino-tubular junction which is the smallest 
diameter in the root of the ascending aorta. As it will be explained further in the 
methodology section, the diameter of the aorta will be used to calculate cardiac output 
with the Doppler aortic velocity (Eq. 5). 
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Left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume 
(LVESV) and ejection fraction (EF) were all calculated from b-mode image of the 
parasternal long axis view of the left ventricle as shown in figure 10. 
 
Figure 10: Parasternal long axis view [modified from www.medscape.com] 
Where RV is the right ventricle, LV is the left ventricle, LA is the left atria and Ao is the 
aorta. 
Cardiovascular variables 
All other cardiovascular variables were recorded while the subject was tilted to the right 
in order to place the subject’s right arm below his heart. According to the method 
developed by Gauer and Sieker in 1956, this is very important for the measurement of 
central venous pressure (CVP). We recorded the venous pressure at the level of the 
junction of the right atrium and the vena cava. Our technique used a saline filled tube 
connected to the previously inserted venous catheter with a pressure transducer (Medex 
Inc., CA, USA) set at the level of the right atrium. The pressure transducer was calibrated 
against a column of water and adjusted to relative pressure by setting the atmospheric 
pressure at 0 cmH2O through a three way stopcock located directly beside the transducer. 
Heart rate (HR) was measured with a three lead electrocardiograph (Pilot 9200, Colin 
Medical Instruments, San Antonio, USA). 
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Blood pressure (BP) was measured continuously from the middle finger of the left hand 
with a photoplethysmograph cuff in accordance with the volume-clamp method 
developed by Peñáz in 1973 and integrated in the Finometer (Finapres Medical Systems, 
Amsterdam, The Netherlands). As described before, the brachial pressure is estimated 
from the finger pressure with a frequency-dependent filter and a height corrector. BP was 
also collected manually with a sphygmomanometer and a stethoscope on the left arm at 
the level of the brachial artery. 
Cardiac output (Q) was first of all estimated from the Modelflow method implemented in 
the Finometer (Finapres Medical Systems, Amsterdam, The Netherlands) [Wesseling et 
al., 1993]. This method simulates a non-linear three element model of the aortic input 
impedance to compute the aortic flow waveform from the finger pressure waveform. The 
estimation of Q from the Modelflow equation incorporates the non-linear elastic 
behaviour of the aorta by means of the Langewouter’s algorithm using the age and sex of 
the subject [Langewouters et al., 1986]. This algorithm does not take into account all the 
individual characteristics and can be calibrated either during the test (against either Q 
values from Doppler ultrasound or aortic diameter taken with an ultrasound device) or 
post test (against Q values from Doppler ultrasound). 
Q has also been computed from the product of the blood flow velocity and the diameter 
of the ascending aorta (Eq 5). The velocity was collected with a Doppler ultrasound 
device (Neurovision Doppler Ultrasound Model 500M, Multigon Industries, Mt. Vernon, 
USA) and a hand-held 2MHz transducer probe pointing at the root of the aorta. The probe 
was used as a transmitter and a receiver: it sends ultrasonic waves that hit red blood cells 
then come back at a different frequency that is dependent on the relative speed of the red 
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blood cells. Only one experienced tester held the probe in place throughout the project to 















 (Eq 5) 
4.1.3- Second Project 
In order to test the hypotheses of the second project we measured the relative effect of 
orthostatic stress on the finger and brachial BP contour in regard to Q estimated from the 
Modelflow method of the Finometer. 
We asked every participant from the previous project to come back one (1) more time in 
the lab. Since we were not looking at any circadian cycle outcome and only at the effect 
of orthostatic stress, one (1) LBNP protocol was performed at the most convenient time 
of the day for the subject. They were asked to sleep 8h and to not drink alcohol or coffee 
for 24h prior to the test. 
We used a 15 min constant LBNP protocol in order to take measurements in steady state 
(after 30 sec of each stage). Figure 11 below show the details of the LBNP protocol. 
 
Figure 11: LBNP protocol of the second project 
In this second protocol, CVP was not measured so this allowed the subjects to be 
positioned in a left lateral tilt position throughout to optimize the ultrasound imaging of 
the heart. The same apparatus was used as in project 1 to collect data for cardiac imaging, 
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aortic blood flow velocity, heart rate and finger arterial blood pressure following the 
same steps explained in section 4.1.2. The reconstructed brachial BP contour was also 
estimated from the FinometerTM. In addition during these experiments, brachial artery 
blood pressure was measured from the brachial artery of the right arm by applanation 
tonometry (SPT-301, Millar Instruments, Houston, Texas, USA) as an estimate of aortic 
BP. In fact, since it is a fairly big artery and it is close to the aorta, doctors usually 
estimate aortic BP via a sphygmomanometer placed on the brachial artery. The Millar 
consists of a micromanometer located in the tip of a probe and placed on the vessel wall. 
It accurately measured the blood pressure profile by flattening the vessel wall under the 
probe and so measuring directly the circumferential pressure. 
Although we are fully aware of the assumption made regarding that both right and left 
brachial artery are the same and would react the same; we decided to not measure the two 
pressures on the same arm to avoid any influence of a manipulation on the other signal. 
In order to remove any hydrostatic difference between the right and the left brachial 
arteries, the reconstructed brachial BP was corrected with the height corrector of the 
Finometer and the finger BP was corrected during the data analysis. 
4.1.4- Data collection system 
Except for the Sonosite, all the instruments were connected to the acquisition hardware 
Powerlab (Powerlab 16 channel SP unit, ADInstruments, Colorado Springs, CO). The 
CVP and the Millar signal were amplified (9200, Colin Medical Instruments, San 
Antonio, USA) before being sent to Powerlab. The Sonosite was connected to a video 
camera (Sony, Tokyo, Japan) that recorded the image shown on the screen. We also used 
the analysis software program Chart (Chart V5.5.1 software, ADInstruments, Colorado 
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Springs, CO) to record the data from the Powerlab at a sample frequency of 1000Hz. The 
Chart program was used for post-recording data analysis via macros that determined beat 
to beat values. 
4.2- Data Analysis 
Different techniques were employed for processing the data in order to investigate the 
hypotheses. This section presents them briefly. 
4.2.1- Development of the Relation 
For this project, we used the post-test data from the Beatscope software of the 
Finometer
TM
. These data accounted for the calibration made to the Langwouter’s 
algorithm. 
First of all, to evaluate the potential error introduced by the different outputs of the 
Finometer
TM
 we compared them to the result obtain from their corresponding 
independent method. HR from the Finometer
TM
 was compared to HR from the Colin. 
SBP and DBP from the Finometer
TM
 were compared to SBP and DBP from the 
sphygmomanometer. The corrected estimation of Q made by the Modelflow model 
transforming finger BP into Qfin was compared to Q from the Doppler ultrasound 
(Qdop). 
Our recent preliminary study [Gagné et al., 2007] has shown a linear relationship 
between CVP and SV using a lower body negative pressure (LBNP) device before and 
after a 4h hour head down tilted bed rest. The equation used is as follow: 
 SVbaCVP ⋅+=  (Eq 6) 
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Where a and b are constants of the simple regression equation. We reasoned that it 
followed the Frank-Starling mechanism with CVP as an indicator of the preload of the 
heart, but further investigations of those preliminary data have shown that this 
relationship is specific to every subject. 
Secondly, in order to increase the accuracy and reliability of the CVP estimation, we tried 
to improve this equation with a multiple regression of specific individual variables 
playing a role in the Frank-Starling mechanism. Knowing that the preload of the heart 
(CVP) influences the stretch of the left ventricle (represented by LVEDV) and the last 
one is also influenced by the filling time of the heart (HR), we decided to use these two 
variables: 
 HRcLVEDVbaCVP ⋅+⋅+=  (Eq 7) 
LVEDV is not an output from the Finometer
TM
 and should be previously calculated from 




baCVP ⋅+⋅+=  (Eq 8) 
Since EF might change with a stress, another regression was created to estimate EF with 






⋅+=  (Eq 9) 
Where a, b, c, k, l and m are constants of the two multiple regressions equations. 
Finally, in order to assess if the general equation is representative of every subject and to 
verify if we increased the accuracy and the precision of the CVP estimations (Eq.9 versus 
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Eq.6); three types of CVP equations were created with Eqs. 6 and 9. The first one is 
specific to every test by using the variables of every single test (Test). The second is a 
little bit more general and represents every single subject (Individual). The last one is 
even more general and represents our group of subjects (General). The CVP values 
calculated with both Eq.6 and Eq.9 were compared with CVP measured with the catheter. 
Given that no standards have been stated in the literature for the accuracy and the 
precision of CVP measurements, we a priori decided that a good approximation of CVP 
measured will have a bias smaller than ± 2mmHg and a precision better than ± 2mmHg. 
These values are chosen considering the accuracy and precision of the reference method. 
4.2.2- Investigation of Cardiac Output Measurement 
At the beginning of the test, in order to calibrate for individual variables not taken into 
account in the Langewouter’s algorithm, we corrected Q directly in the display of the 
Finometer
TM




 Modelflow method of estimating Q was examined relative to the 
Doppler method to determine the percent change in the discrepancy of SV with change in 
TPR during progressive levels of LBNP as conducted previously in the unpublished 
results from Dyson and colleagues. The initial objective was to determine if increasing 
distortion of finger BP compared to aortic BP during LBNP contributed to the 
Modelflow-Doppler differences. An equation was developed (see appendix) allowing for 
the calculation of SV and Q from the reconstructed brachial BP signal and the Millar BP 
signal which could have been compared to Doppler ultrasound. 
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Unfortunately, the program running the equation did not give accurate values of SV and 
Q. The difficulty of stating the variable tau (τ) in the equation (see appendix) is probably 
the major source of error. Tau (τ) is a “time-constant” used in the calculation of the 
resistance offered by the Windkessel arterial compliance element (CW). The literature 
about it is very confusing and even sometimes points in different directions. 
In order to look at the influence of different BP shape on the estimation of Q and SV, an 
alternative method was developed. This approach would allow conclusions about the 
finger versus brachial blood pressure signal as a potential source of deviation of SV from 
the Doppler method (primary objective of the second hypothesis) and about the 
possibility of improving the result with reconstructed brachial BP (objective of the third 
hypothesis). However, this approach would not allow conclusions about the second and 
third hypotheses per se. 
Alternative method 
As explained in section 2.5.3, the Modelflow method implemented in the Finometer
TM
 
takes into account several physiological characteristics to create a “conversion factor” 
used to change the systolic part of the finger BP waveform into an aortic flow waveform. 
SV is then calculated by the integral of the aortic flow waveform and Q is calculated with 
the following equation: 
 HRSVQ ⋅=  (Recall of Eq 3) 
An integral of a function is actually the area underneath its curve. This area can be 
calculated by adding up rectangles with a height starting at the base and touching the 
aortic flow contour and a length of our choice. Since we recorded our data with a 
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sampling frequency of 1000 Hz, we used a length of 0.001s. Figure 12 presents this 
concept with a typical flow waveform and larger rectangles in order to see them: 
 
Figure 12: Area underneath the curve of a typical aortic flow waveform 


















 (Eq 10) 
Where the “conversion_factor” is unknown. 
The “conversion factor” is very specific to every single beat of one subject because the 
modelflow model takes into account: age, sex, diastole time of the current beat, MAP of 
the previous beat and Q of the previous beat. Therefore, if BP is monitored with three 
different methods for one beat, the “conversion factor” will be the same for these three 
methods. This allows us to compare the estimation of finger BP and brachial BP with 
Millar BP, our reference method. 
Figure 13-A shows an example of finger BP and Millar BP contours over the course of a 
heart beat. The methods do not have the same BP contours during systole and we want to 
see if the difference between them can lead to an error in the calculation of Q. The 
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computation of the area underneath the curve of BP is adjusted to take into account only 
the pulse pressure (PP) component like it is shown in Figure 13-B. 
 
Figure 13: A) Finger BP and Millar BP over the course of a heart beat; B) Finger PP and 
Millar PP during systole 
Since they both have the same “conversion factor”, simply comparing the area 
underneath the curve of both BP contours is sufficient. But in order to visualise their 
differences, we plotted them against each other (Figure 14-B). The result gives 
information about the amplitude of the over and underestimation of Millar BP by finger 
BP. This can potentially explain the reason why brachial BP is better or not than finger 
BP. 
As seen in Figure 14, for a same length of time, finger BP overestimated at first Millar 
BP and underestimated it at the end of the systole. The addition of both effects can lead to 
the cancelation of the error. 
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Figure 14: Over and underestimation of Finger BP over Millar BP; A) Finger BP and 
Millar BP over the course of a heart beat; B) Finger BP vs Millar BP during systole 
The “conversion factor” is unknown but it is taken as being the same for each individual 
beat independent of the method of BP measurement (finger, estimated brachial or Millar). 
Thus, it is possible to eliminate this factor in the calculation of Q error relative to the 
reference Qmillar. 
For one specific beat the conversion factor is a constant and can be placed outside the 
summation component of Equation 10. This allows its cancellation in the following 





















































































































 (Eq 12) 
In order to asses if BP difference does play a role or not in Qfin-Qdop discrepancy, we 
completed our analysis by comparing the error of Qfinger and Qbrachial over Qmillar 
versus change in TPR and the error between Qfin and Qdop. 
Validation of the Millar 
Even though the Millar device is known to give accurate estimates of the BP contours, it 
is important to validate that Q calculated from the Millar (Qmillar) will be a reference 
just like Q measured from the Doppler ultrasound (Qdop). 
Knowing that Qfin is calculated from the finger BP contours and that Qdop correspond to 




















The absolute value of these ratios has absolutely no physiological meaning, but the 
comparison of them will give information about the validity of using Millar PP. 
 45 
In order to validate if Q calculated from the Millar is a good reference, we plotted 
Qfinger/Qfin versus Qmillar/Qdop. If the data follow the identity line, it shows that 
Qmillar is a good representation of Qdop. 
Indeed, Qfinger/Qfin is the “perfect match” as Qfinger is a representation of Qfin. If 
Qmillar/Qdop = Qfinger/Qfin that means that Qmillar/Qdop is also a “perfect match”. 
Thus, if Qmillar/Qdop = Qfinger/Qfin then it means that the Qmillar is a good 
representation of Qdop. 
4.3- Statistical analysis 
Statistical analyses were done through SigmaStat version 3.5 (Systat Software, Inc, 
Chicago, Illinois, USA). 
In order to assess the agreement between the different techniques of measurement we 
performed a Bland-Altman analysis. Since this technique does not quantify statistical 
differences between methods, we used another technique: One-Way-Repeated-Measures-
Analysis-of-Variance (1-way-RM-ANOVA). This approach has been performed to 
compare every LBNP stage to baseline of each variable measured during both test 
(Figure 15-B and Figure 22) and every output of the FinometerTM (HR, DBP, SBP, Q) to 
their corresponding independent method at every LBNP stage. CVP calculated has also 
been statistically compared to CVP measured at every LBNP stage with this method. We 
used Tukey’s test for all these comparisons. In cases where either the normality test or the 
equal variance test failed, we executed the non-parametric test Friedman-1-way-RM-
ANOVA. 
Differences were considered statistically significant when p<0.05. 
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We used a multiple linear regression to create all the CVP relations and a simple linear 
regression to create the EF relation. The t-test has been used to assess if the independent 
variables used in the equations significantly contribute to predict CVP and EF. 
Variables that contributed to prediction of the independent variable were included when 
p<0.05. 
We also used a simple linear regression to examine the relation between Q discrepancies 
and change in TPR. 
Finally, we used the t-test to compare Qfinger discrepancy with Qbrachial discrepancy at 
both baseline and -40mmHg. 
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5. Results 
5.1 Participant Characteristics 
Characteristics of participants in project 1 and project 2 are compared in Table 4. Eight 
participants have been studied in both projects. Four of the participants in project 1 took 
part of project 2. Both groups of participants had similar age, height, weight, HR, SBP 
and DBP. 
In project 1, 23 tests out of the 40 tests available were included in the analyses. In project 
2; all 8 tests were used. Criteria of test rejection from the pool of test in project 1 are 
shown in Table 5 along with the number of tests rejected for each reason given. 
5.2 Development of the Relation 
Physiological Variables during Orthostatic Stress 
Figure 15-A illustrates an example of one subject’s physiological response during the 
LBNP protocol of project 1. In order to record other responses relevant to my colleagues, 
Q, SV, CVP and TPR measurements have been shortly interrupted during the test. The 
average values for every LBNP stage were calculated and compiled with the other 
subjects to create Figure 15-B. HR during the first two stages of the LBNP (-10 mmHg 
and -20 mmHg) was unchanged. HR became significantly elevated from baseline for the 
two last stages of LBNP (-30 mmHg and -40 mmHg) (p<0.05). MAP was unaffected 
throughout the test. Q, SV and CVP were unchanged from baseline at -10 mmHg, but 
were significantly reduced at -20 mmHg, -30 mmHg and -40 mmHg (p<0.05). TPR was 
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unchanged for the first LBNP stage and was elevated for the second, third and fourth 
LBNP stage (p<0.05). 
Accuracy and Precision of the Different Outputs of the Finometer
TM
 
A summary of the accuracy and the precision of the different outputs of the Finometer
TM
 
is presented in Table 6. 
HR measured from the Finometer
TM
 appeared to be accurate and precise at every stage of 
the LBNP. As shown in Figure 16, the overall bias was 0.05 beats/min with an error of 
0.18 beats/min. No particular pattern can be observed in Figure 16, suggesting that the 
error was not related to the orthostatic stress effect. 
DBP from the Finometer
TM
 was within AAMI standard while its error was offset (8.8 
mmHg compared to ±8 mmHg). There was no significant difference between DBP 
measured with the FinometerTM and the sphygmomanometer. On the other hand, SBP 
measured with the FinometerTM was significantly different from SBP measured with the 
sphygmomanometer (p<0.05) and did not meet the AAMI standard for the accuracy (14.2 
mmHg compared to ±5 mmHg) just met it for the precision with a small offset (8.0 mmHg 
compared to ±8 mmHg). Figure 17 illustrates the accuracy and the precision of both DBP 
and SBP. 
Q measured from the FinometerTM was not significantly different from Q measured with 
Doppler at baseline, -10 mmHg and -20 mmHg but became significantly higher at               
-30 mmHg and -40 mmHg (p<0.05). Throughout the test, Qfin had a smaller precision 
than it would if measured with the thermodilution technique (8%). Qfin post-test-
correction with the Beatscope of the Finometer
TM
 brought baseline Qfin data to the same 
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level of baseline Qdop data (Figure 15). This operation decreased the overall bias and 
error as shown in Figure 19 (0.797± 1.122L/min to 0.255± 0.441L/min) and considerably 
increased the precision of Qfin for baseline, -10 mmHg and -20 mmHg relative to that 
reported for the thermodilution technique. Qfin corrected was not significantly different 
from Q measured with Doppler at baseline and for the two first LBNP stages but became 
significantly higher for the two last LBNP stages (p<0.05). No particular pattern can be 
distinguished in the Doppler-vs-Finometer graph of Figure 16, but a negative slope can 
be observed in the Doppler-vs-Finometer_corrected graph. This shows that the accuracy 
decreases (bias increases) when Q decreases during orthostatic stress. 
Development of the CVP Equation 
The equation to determine EF is presented in the Appendix. The constant used in this 
equation, did not significantly contribute to predict the dependent variable (p>0.05), but 




 DBPEFrestEF ⋅+⋅+= 104.0881.0471.1  
The details of general, individual and test equations for both relations with either Doppler 
or Finometer
TM
 are all presented in the Appendix. The general equations for the newly 



























The general equations for the relation developed by Gagné and colleagues (2007) are: 
-With Doppler (R2= 0.242): 
SVCVP ⋅+= 0721.0291.0  
-With FinometerTM (R2= 0.232): 
SVCVP ⋅+−= 0794.0795.0  
According to Table 10, the constants and all the independent variables used in these 
general equations significantly contribute to predict CVP (p<0.05). 
Accuracy and Precision of CVP Calculated 
The summary of the accuracy and precision of CVP calculated with both relations in 
comparison of CVP measured with the venous catheter are presented in Table 7. The 
calculated CVP values were not significantly different from their corresponding CVP 
measured. CVP calculated from the general equations of the newly developed relation 
were not significantly different from CVP calculated from the individual or test 
equations. CVP calculated from the general equations of the relation developed by Gagné 
and colleagues (2007) were not significantly different from CVP calculated with the 
individual or test equations with the exception that CVP calculated from the general 
equation with SVdop was significantly different from CVP calculated from the test 
equation (at -40 mmHg and overall) (p<0.05). CVP calculated from the individual 
equations were not significantly different from CVP calculated with their corresponding 
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test equations. CVP calculated with SVfin was not significantly different from their 
corresponding CVP calculated with SVdop. CVP calculated with the newly developed 
relation was not significantly different from their corresponding CVP calculated with the 
relation developed by Gagné and colleagues (2007). 
Figure 20 depicts the overall accuracy and precision of CVP calculated with the 
equations of the newly developed relation in comparison to CVP measured with the 
venous catheter. CVP calculated with general equations using either Doppler or 
FinometerTM showed a negative but similar slope pattern. CVP calculated with individual 
equations using either Doppler or Finometer
TM
 showed once again a negative slope, but 
this time both datasets showed a smaller slope. CVP calculated with test-specific 
equations using either Doppler or Finometer
TM
 showed an even flatter negative slope. 
The same observations can be made in Figure 21 which illustrates the overall accuracy 
and precision of CVP calculated with the equations of the relation developed by Gagné 
and colleagues (2007) in comparison to CVP measured with the venous catheter. Both 
relations show very similar corresponding overall results (Figure 20 compared with 
Figure 21). 
Overall, the individual and test equations from both relations (Table 7) were within the 
standards stated a priori (Accuracy< ±2 mmHg, Precision better than ±2 mmHg). The 
accuracy (bias) of the general equations met the standard while the precision was not 
good enough (worse than ±2 mmHg) in all the cases. 
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5.3 Investigation of Cardiac Output Measurement 
Physiological Variables during Orthostatic Stress 
Physiological variables during LBNP of project 2 are illustrated in Figure 22. HR during 
the first two stages of the LBNP (-10 mmHg and -20 mmHg) was unchanged. HR became 
significantly elevated from baseline for the two (last stages of the LBNP, -30 mmHg and 
-40 mmHg) (p<0.05). Q and SV were unchanged at -10 mmHg compared to baseline, but 
were significantly reduced at -20 mmHg, -30 mmHg and -40 mmHg (p<0.05). MAP 
stayed unaffected throughout the test. TPR was unchanged for the first and second LBNP 
stage and was elevated for the third and fourth LBNP stage (p<0.05). TPR calculation 
does not include CVP (TPR=MAP/Q). 
Accuracy and Precision of Cardiac Outputs from the Finometer
TM
 
As shown in Figure 23, Q measured from the FinometerTM was not significantly different 
than Q measured with Doppler at baseline, -10 mmHg, -20 mmHg and -30 mmHg but 
became significantly higher at -40 mmHg (p<0.05). 
Figure 24 illustrates that Qfin-Qdop discrepancy increased when TPR increased. For a 
change of 10 mmHg/L/min, Qfin-Qdop discrepancy increased in average by 31.6%. 
Validation of Cardiac Output estimated from the Millar 
Figure 25 presents the validation of Q estimated from Millar. All beats analysed are 
represented on the graph by comparing two (2) ratios: Qfinger/Qfin with Qmillar/Qdop. 
A dot on the identity line shows a perfect representation of Qdop by Qmillar. The further 
the dot is from the identity line, the worse is the representation of Qdop by Qmillar. 
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The cloud of dots is quite large but does cover both side of the identity line. This suggests 
a good estimation of Qdop by Qmillar. 
Identification of the Major Source of Error 
At baseline, Figure 26 presents an example of finger BP and brachial BP versus Millar 
BP during systole for every subject. In general, brachial BP was closer to the identity line 
suggesting that it followed very well Millar BP while finger BP had bigger over- and 
underestimation. In all cases, the initial upstroke of finger BP started by overestimating 
Millar BP and always peaked over our reference method. During the following down 
stroke, finger BP passed under the identity line showing an underestimation of Millar BP. 
This pattern implied a higher but narrower peak of all Finger BP compared to Millar BP 
during baseline. In subject 1 and 8, brachial BP followed very well Millar BP. Millar BP 
was overestimated by brachial BP in subject 3, 4, 6 and 7, while it was underestimated in 
subject 2 and 5. Note that in all cases brachial BP either overestimated or underestimated 
Millar BP, but never crossed the identity line like finger BP did. Except for subjects 1, 6 
and 8, the initial upstroke of all brachial BP moved away from the identity line and came 
back closer during the down stroke. This suggested that brachial BP of subjects 3, 4 and 7 
had a higher but just a little bit narrower peak than Millar BP and brachial BP of subject 2 
and 5 had a lower but just a little bit wider peak than Millar BP. In subject 6, brachial BP 
followed very well Millar BP during the upstroke, but then overestimated it; implying an 
equal but wider peak than Millar BP. 
Figure 27 presents an example of finger BP and brachial BP versus Millar BP during 
systole for every subject at -40 mmHg. In general, the same observations made for 
baseline can be made at -40 mmHg. Finger BP overestimated then underestimated Millar 
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BP. In subject 1 and 2, brachial BP followed very well Millar BP. Millar BP is 
overestimated by brachial BP in subjects 3, 4, 7 and 8, while it is underestimated in 
subjects 5 and 6. In contrast to Figure 26 and except for subjects 2 and 5, we can observe 
in Figure 27 that the end of the down stroke (dicrotic notch BP) went closer to the initial 
pressure (diastolic BP). 
Table 8 presents the error of Qfinger and Qbrachial in comparison to Qmillar. These 
values represent the normalised difference between areas underneath the curves presented 
in Figures 26 and 27. At baseline, Qfinger discrepancy (-1.13 ± 14.67%) was smaller but 
not significantly different than Qbrachial discrepancy (8.80 ± 17.28%) (p>0.05). It was 
also bigger but not significantly different than Qfinger discrepancy at -40mmHg (-0.61 ± 
9.33%) (p>0.05). During the last stage of the LBNP at -40 mmHg, Qfinger discrepancy 
was smaller but not significantly different than Qbrachial discrepancy (9.74 ± 11.95%) 
(p>0.05). On an individual basis, there was no difference between the ability of 
Qbrachial (50%) or Qfinger (50%) to provide the best estimate of Qmillar, with no major 
differences between baseline and -40 mmHg LBNP. 
Figure 28 shows no particular pattern between Qfinger discrepancy and Qbrachial 
discrepancy with change in TPR. Qfinger discrepancy and Qbrachial discrepancy 
responded in the same direction and almost in the same amount with a change in TPR 
(0.42% in comparison to 0.53% for a change of 1 mmHg/L/min). 
Figure 29 shows no particular pattern between Qfinger-Qmillar discrepancy and 
Qbrachial-Qmillar discrepancy with Qfin-Qdop discrepancy. Qfinger-Qmillar 
discrepancy and Qbrachial-Qmillar discrepancy responded in the same direction and 
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almost in the same amount with a change in Qfin-Qdop discrepancy (0.12% in 
comparison to 0.11% for a change of 1%). 
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5.4 Figures and Tables 
 
Table 4: Participant characteristics for both projects 
 Project 1 Project 2 
Number of subjects 8 8 
Number of tests used 23 8 
Age (years) 24± 5.0 24.4± 4.3 
Height (cm) 175.7± 5.9 177.1± 7.7 
Weight (kg) 72.2± 6.8 74.6± 6.4 
At Rest:   
HR (Beats/min) 52.05± 6.10 56.21± 11.58 
SBP (mmHg) 125.4± 11.5 125.5± 13.9 
DBP (mmHg) 67.2± 6.5 72.6± 6.1 
All values are mean ± SD. 
 
 
Table 5: Criteria of test rejection from the pool of test in project 1 
Nb test rejected Reason 
6 Missing data from the Beatscope of the FinometerTM 
5 
Missing data because of problems encountered with measurement 
instrument (Doppler or CVP apparatus) 
4 
Hyperactive subject causing unexpected responses in variables 
during our passive orthostatic stress 
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Figure 15-A: Example of physiological variables of one subject during the LBNP protocol of 
project 1 – Beat-by-Beat representation 
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Figure 15-B: Physiological variables during LBNP of project 1 
All Values are mean ± SD, n=23. * Significantly different from baseline (p<0.05). 
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Table 6: Summary of the accuracy and precision of the different outputs of the FinometerTM 
in project 1 
  0 -10 -20 -30 -40 Overall 
HR 0.04± 0.11 0.02± 0.16 0.07± 0.13 -0.001± 0.23 0.12± 0.21 0.05± 0.18 
DBP 1.6± 8.8      








0.928± 0.999 * 
(26.6%) 












0.406± 0.466 * 
(10.9%) 




All values are bias ± SD (Accuracy ± Precision), n=23. Values in parenthesis are %error               
((Qfin-Qdop)/Qdop). * Variable is significantly different from reference method (p<0.05). 
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Figure 16: Accuracy and precision of HR measured by the FinometerTM in comparison with 
HR measured from the electrocardiograph in project 1 – Bland-Altman Analysis 
Total of 115 observations in 23 tests 
 
DBP Average (mmHg)



























































Figure 17: Accuracy and precision of DBP and SBP measured by the FinometerTM in 
comparison with DBP and SBP measured from the sphygmomanometer in project 1 – 
Bland-Altman Analysis 
Total of 23 observations in 23 tests 
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Figure 18: Effect of the correction of Q from the FinometerTM in comparison of Q from the 
Doppler in project 1 
All Values are mean ± SD, n=23. * Finometer is significantly different from Doppler (p<0.05). 
 
 
Figure 19: Accuracy and precision of Q from the Doppler and Q from the FinometerTM non-
corrected and corrected in project 1 - Bland-Altman analysis 
Total of 115 observations in 23 tests 
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Table 7: Summary of the accuracy and precision of CVP calculated with both the newly 
developed relation (New relation (Eq. 9)) and the relation developed by Gagné and 
colleagues (2007) (Old relation (Eq. 6)) in comparison of CVP measured with the venous 
catheter in project 1 
      0 -10 -20 -30 -40 Overall 
Doppler -2.0± 2.1 -0.3± 2.6 1.0± 2.7 1.8± 2.4 1.8± 2.1 0.4± 2.8 
General 
Finometer -2.5± 2.1 -0.5± 2.6 1.1± 2.3 2.0± 1.9 2.1± 1.8 0.4± 2.8 
Doppler -1.8± 1.1 -0.2± 1.2 1.0± 0.8 1.2± 0.9 0.8± 1.1 0.2± 1.5 
Individual 
Finometer -2.1± 1.1 -0.2± 1.2 1.2± 0.8 1.5± 0.9 0.9± 1.1 0.2± 1.7 

















Finometer -1.7± 0.7 0.1± 0.6 1.0± 0.6 0.9± 1.0 0.3± 0.8 0.1± 1.2 






Finometer -2.5± 2.2 -0.6± 2.6 1.0± 2.3 2.0± 2.0 2.0± 1.8 0.4± 2.8 
Doppler -1.7± 1.4 -0.2± 1.5 0.8± 1.4 1.3± 1.4 1.1± 1.1 0.2± 1.8 
Individual 
Finometer -2.3± 1.5 -0.4± 1.6 1.0± 1.3 1.7± 1.3 1.4± 1.2 0.3± 2.0 















Finometer -1.7± 0.7 0.01± 0.7 0.9± 0.6 1.1± 0.9 0.5± 0.9 0.2± 1.3 
All values are bias ± SD (Accuracy ± Precision), n=23. * CVP calculated is significantly different 
from CVP measured with the catheter (p<0.05). 
#
 General equation is significantly different from 
corresponding Test equation (p<0.05). 
†
 General equation is significantly different from 
corresponding Individual equation (p<0.05). 
&
 Individual equation is significantly different from 
corresponding Test equation (p<0.05). 
α
 CVP calculated with Finometer’s SV is significantly 
different from CVP calculated with Doppler’s SV (p<0.05). 
β
 New relation is significantly 
different from Old relation (p<0.05). 
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CVP Average (mmHg)
























































































































































































Figure 20: Accuracy and precision of CVP calculated with a general, an individual and a 
test-specific equation with the newly developed relation (Eq. 9) in comparison of CVP 
measured with the venous catheter in project 1 – Bland-Altman analysis 
Total of 114 observations in 23 tests 
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Figure 21: Accuracy and precision of CVP calculated with a general, an individual and a 
test-specific equation with the relation developed by Gagné and colleagues (2007) (Eq. 6) in 
comparison of CVP measured with the venous catheter in project 1 – Bland-Altman 
analysis 

























































































Figure 22: Physiological variables during LBNP of project 2 
All Values are mean ± SD, n=8. * Variable is significantly different from baseline (p<0.05). 
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Figure 23: Effect of during-test-correction of Qfin directly in the display of the FinometerTM 
in comparison of Q from Doppler in project 2 
All Values are mean ± SD, n=8. * Finometer is significantly different from Doppler (p<0.05). 
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Figure 24: Q discrepancies versus change in TPR 
Total of 40 observations in 8 tests 
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Qmillar/Qdop




















Figure 25: Validation of using Qmillar as a reference for Qdop 
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Figure 26: Finger BP and Brachial BP versus Millar BP for every subject during Baseline 
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Figure 27: Finger BP and Brachial BP versus Millar BP for every subject at -40mmHg 
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Table 8: Summary of Qfinger discrepancy and Qbrachial discrepancy 










1 -6.65 2.94 -9.21 0.56 
2 -18.93 -11.29 -9.35 -2.34 
3 9.01 23.21 11.26 28.34 
4 25.23 41.07 7.99 20.42 
5 -16.76 -9.34 -6.05 1.31 
6 -0.32 7.84 -11.70 -2.68 
7 7.26 14.03 5.11 16.90 
8 -7.85 1.98 7.08 15.43 
Average 
± SD 
-1.13 ± 14.67 8.80 ± 17.28 -0.61 ± 9.33 9.74 ± 11.95 
* Average Qfinger discrepancy during baseline is significantly different from average Qfinger 
discrepancy at -40mmHg (p<0.05). 
#
 Average Qbrachial discrepancy during baseline is 
significantly different from average Qbrachial discrepancy at -40mmHg (p<0.05). & Average 






























































































y = -0.42x + 1.71
R² = 0.0213





Figure 28: A) Qfinger dicrepancy vs change in TPR; B) Qbrachial discrepancy vs change in 
TPR 
Total of 12 observations in 8 tests 
Qfin-Qdop discrepancy
                (%)
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y = 0.12x - 0.89
R² = 0.0664





Figure 29: Qfinger-Qmillar discrepancy vs Qfin-Qdop discrepancy; B) Qbrachial-Qmillar 
discrepancy vs Qfin-Qdop discrepancy 
Total of 12 observations in 8 tests 
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6. Discussion 
The aim of this thesis was to develop a non-invasive method to monitor cardiovascular 
control during orthostatic stress. The first steps of the development of this method have 
been separated in two different projects covering three hypotheses. 
We first found that the Finometer
TM
 had the potential to accurately and precisely be used 
alone to monitor cardiovascular control during orthostatic stress. It did not give perfect 
values, but proper use including calibration of the Finometer
TM
 can lead to results for 
heart rate, SBP and DBP with sufficient accuracy and precision to be valid in most 
research settings at rest and during mild stress. Secondly, the estimations of CVP made 
with a general equation are accurate, but contrary to our first hypothesis, not reliable. 
Individual and test equations gave accurate and precise estimations of CVP, opening 
opportunities of non-invasive estimations of CVP with a prior test specific adjustment 
(i.e. correction against CVP directly measured). Moreover, using SV from the 
Finometer
TM
 to calculate CVP has been shown to be not significantly different than using 
SV from the Doppler. Finally, the newly developed equation (Eq. 9) did not improve the 
results of Gagné and colleagues (2007) (Eq. 6). 
Hypothesis 2 that using finger BP to represent aortic BP would influence the discrepancy 
in the estimation of Q by Finometer
TM
 compared to the Doppler estimate of Q when a 
stress was applied was not supported by the current study. Further investigation of this 
discrepancy in hypothesis 3 revealed that while brachial BP gave a better estimation of 
absolute value of Millar BP, the shape of the finger BP was not the source of a 
discrepancy between Q FinometerTM and Q Doppler. New details concerning the pulse 
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wave contour obtained by plotting the instantaneous BP during the cardiac ejection phase 
showed that an over-estimation of BP by the finger BP relative to the Millar BP early in 
the cardiac cycle was compensated almost perfectly by under-estimation in the latter part 
of the cardiac ejection phase. 
The following sections examine the causes of these results. 
6.1 Development of the Relation 
Physiological Variables during Orthostatic Stress 
The physiological variables recorded during project 1 (Figure 15) are in accordance with 
the literature covering orthostatic stress. CVP, SV and Q gradually decreased with the 
increasing orthostatic stress due to the decrease of blood going back to the heart [Rowell, 
1993]. In order to maintain sufficient arterial blood pressure (MAP) to drive blood to the 
brain, reflex responses from the autonomic nervous system were able to increase HR and 
TPR (vasoconstriction) [Rowell, 1993]. 
Figure 15 also shows that the first stage of the LBNP (-10 mmHg) did not create 
significant changes in all physiological variables. This concords with the fact that a 
LBNP stage of -10mmHg is comparable to a head-up tilt of less than 60° [Kitano et al., 
2005], which is much milder compared to -40mmHg LBNP representing an upright 
position [Musgrave et al., 1969; Butler et al., 1993]. In light of these observations, we 
confirm that the dataset used to create the CVP equations conformed to the expected 
response during an orthostatic stress. 
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Accuracy and Precision of the Different Outputs of the Finometer
TM
 
According to our results, HR calculated from the working frequency of the finger cuff 
gives accurate and precise values in comparison of HR measured with an 
electrocardiograph. Its accuracy and precision are not affected by the stress applied. 
DBP and SBP discrepancies are not all in agreement with the literature. The accuracy of 
DBP (1.6 mmHg) is within the AAMI standard, but its precision (8.8 mmHg) is a little bit 
offset. This conflicts with the data of Guelen and colleagues (2008) (4± 6 mmHg) and the 
data presented in the Finometer
TM
 User’s Guide (1± 5 mmHg), where both studies 
showed accurate and precise estimation of DBP of the reconstructed brachial BP 
waveform. SBP accuracy (12.2 mmHg) is not within the AAMI standard and does not 
concord with what has been found in the previous studies [Guelen et al., 2008; 
FinometerTM User’s Guide]. Although SBP precision (8.0 mmHg) is considered 
borderline to the AAMI standard, it is in conformity with what Guelen and colleagues 
(2008) (8 mmHg) and the Finometer
TM
 User’s Guide (7 mmHg) have shown. The 
discrepancies seen in our results compared to the two references studies are probably 
caused by the use of a different reference method. Both studies refer their brachial 
measurements to intra-arterial pressure instead of manual BP (sphygmomanometer). 
Considering that the intra-arterial technique is direct; its accuracy is higher then manual 
BP, which makes the comparison different. According to the AAMI, cuff/stethoscope 
auscultatory measurements may be used as a reference standard, but trained observers are 
required [White et al., 1993]. The error seen in our results might come from the fact that 
different and non-trained observers collected manual BP. 
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The overall Q, pre and post calibration, are in accordance with the literature. Indeed, Qfin 
(0.797± 1.122mmHg) and Qfin-corrected (0.255± 0.441mmHg) concord with the data 
presented in the FinometerTM User’s Guide and shows that a calibration is needed in 
order to represent absolute value instead of only variations of Q [Harms et al., 1999]. 
Following the results of van Lieshout and colleagues (2003), we also found that the 
accuracy of the estimation of Q from the Finometer
TM
 decreased when an orthostatic 
stress was applied (Figures 18 and 19). This result will be discussed in more detail in 
section 6.2. 
Accuracy and Precision of CVP Calculated 
Although EFrest, DBP, SV and HR significantly contributed to predict CVP in the 
general CVP equations (Table 10), the accuracy and precision of the equations using 
different techniques and in comparison to the relation Gagné and colleagues (2007) 
developed are giving some interesting results. 
Overall, following the standards we stated a priori (bias< ±2 mmHg and precision better 
than ±2 mmHg), CVP calculated appears to be accurate in all three types of equations, 
but is precise only for test and individual equations. The general equations are not 
precise. This suggests that variability between people is not explained or is not explained 
solely by the specific and personal value we added in the equation (left ventricular 
distensibility (EF)). It might also put in evidence the importance of normalising SV data 
to body surface area in order to take into account other variables touching indirectly the 
heart function and the Frank-Starling mechanism. 
According to Table 7 and Figures 20 and 21, CVP calculated using SV from the 
FinometerTM is not significantly different from CVP calculated using SV from the 
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Doppler. At first, this result is surprising considering that the accuracy of the estimation 
of Qfin (SVfin) has been shown to decrease when a stress occurs (Figures 18 and 19). 
Even though SV variable (b) is small in every equation (Table 10), it will be a mistake to 
conclude that the SV discrepancy does not influence CVP calculated because it takes a 
minor place in the equation. Indeed, we should take into account that SV and LVEDV 
(SV/EF) values are in the hundreds range and should be decreased to the CVP range, 
around 10. The similar results between CVP calculated using SVfin and CVP calculated 
using SVdop can be rather explained by the use of two different sets of SV data 
(Finometer
TM
 and Doppler) to extract the regressions. The regression equation for the 
CVP calculated with FinometerTM seems to damp the SV problem by taking into account 
its variation. 
Comparing Figure 20 and Figure 21 also shows that the newly developed relation gives 
similar results as the equation developed by Gagné and colleague (2007). Although our 
equation failed to improve the accuracy and precision of CVP calculated with our current 
set of subjects, it will be appropriate to test this equation on a different population before 
concluding that the added variables are not doing what we expected. For example, it has 
been shown that performances of healthy and normal hearts are not strongly influenced 
by after-load (DBP) while performances of old hearts are more sensitive to a change in 
DBP [Swine, 1992]. Also, EF is influenced by inotropic agents, aging [Fleg, 1986] and 
prolonged bed rest [Levine et al., 1997]. Furthermore, compared to young subjects during 
a stress, the maximum HR is reduced in the elderly but SV is increased to maintain Q 
[Swine, 1992]. Testing our equation on different populations in different situations would 
give more valuable information about the necessity of using DBP, EF, SV and HR. If 
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useful, these variables will help providing more accurate and precise results than the 
equation developed by Gagné and colleagues (2007) for test on other populations. 
Overall, general equations are not precise enough to be used in clinical and research 
setting, but the fact that individual and test equations give good approximations of the 
actual CVP is promising. Individual equations have proven to be not significantly 
different than test equations even though subjects have been monitored many times over 
a long period (reaching a year in one particular case). This suggests the ability to derive a 
personal equation by using a catheter only once that will be useful over a long period for 
similar tests. Further tests will be needed to determine how accurately and precisely this 
equation will estimate CVP in different conditions. 
6.2 Investigation of Cardiac Output Measurement 
Although the problem of Q (SV) discrepancy with an orthostatic stress did not seem to 
influence the CVP equation, it is still very important to insure that we get good results out 
of the Finometer
TM
. This section focuses on the calibration of Q measurement. 
Physiological Variables during Orthostatic Stress 
Even though project 2 did not use the same timeline as project 1, the physiological 
variables recorded during project 2 (Figure 22) are in accordance with the literature and 
are very similar to project 1. SV and Q gradually decreased with the increasing 
orthostatic stress due to the decrease of blood going back to the heart [Rowell, 1993]. In 
order to maintain sufficient arterial blood pressure (MAP) to drive blood to the brain, the 
autonomic nervous system sent efferent signals to increase HR and TPR 
(vasoconstriction). 
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Figure 22 also points out that the first stage of the LBNP (-10mmHg) did not created 
significant changes in all physiological variables, just like in project 1. 
Accuracy and Precision of Cardiac Outputs from the Finometer
TM
 
The differences between Qfin and Qdop illustrated in Figure 23 are in accordance with 
what we found in project 1 (Figure 18) and follow the results of van Lieshout and 
colleagues (2003). Indeed, our results showed an increasing discrepancy between the 
estimation of Q from the Finometer
TM
 and Q from Doppler when an orthostatic stress was 
applied. Furthermore and in accordance to the unpublished data of Dyson and colleagues, 
Figure 24 shows that Q discrepancy was correlated to change in TPR. 
The correction made in the display of the Finometer
TM
 against aortic diameter at the 
beginning of the test in order to account for individual characteristics did not increase the 
accuracy of the measurement (Figure 23 in comparison with Figure 18). Post- test 
calibration with the Beatscope software against Q values from Doppler ultrasound seems 
to remain more efficient (Figure 18-B). 
Validation of Cardiac Output estimated from the Millar 
Figure 25 compares two ratios that, regardless of the absolute value, would give the same 
result only if Qmillar perfectly represents Qdop. Every dot on Figure 25 corresponds to a 
beat analysed. The further the dot is from the identity line, the poorer is the representation 
of Qdop by Qmillar. 
The cloud of dots in Figure 25 is quite large but does cover both side of the identity line. 
Even if this result suggests a reasonably good estimation of Qdop by Qmillar, analysis of 
more beats would be required in order to firmly validate its use. This is the first time, to 
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the author’s knowledge, that this approach has been taken to examine the relationship 
between two independent methods of estimating Q. 
Identification of the Major Source of Error 
When compared to Millar BP during baseline, finger BP showed big overestimations 
during the initial upstroke and big underestimation during the following down stroke 
(Figure 26). This behaviour is in accordance with the literature and suggests that finger 
BP had a bigger pulse pressure, but a narrower systolic peak pressure than aortic BP 
[Remington and Wood, 1956]. Our results for the comparison of brachial BP and Millar 
BP are also in accordance with the same literature. Indeed, because of its proximity to the 
aorta, it was expected to see brachial BP better following Millar BP than finger BP did. 
Interestingly, Table 8 reveals that Qfinger discrepancy during baseline was low (-1.13 ± 
14.67 %) even though finger BP did not follow Millar BP very well. It is important to 
note here that Qfinger discrepancy is not the average of the bias between finger BP and 
Millar BP, but rather the normalised difference between the area underneath finger BP 
contours and Millar BP contours. This suggests that the area underneath the finger BP 
contours was similar to the area underneath the Millar BP contours, but it was distributed 
differently. Finger pulse pressure was greater than Millar pulse pressure, but systolic peak 
pressure was narrowed compared to our reference: the big overestimations of finger BP 
were then cancelled by big underestimations. 
Small visual dissimilarities and minor discrepancies can be distinguished in the 
estimation of Millar BP by finger BP at baseline and during a stress (Figure 27). Even if 
we would have expected a more noticeable alteration, this result is in accordance with the 
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literature and show a different change in the finger artery than in the aorta during an 
orthostatic stress [Houtman et al., 1999; Westerhof and O’Rourke, 1995; Stok et al., 
2006]. Although finger BP is influenced differently than aortic BP during change in TPR, 
Table 8 shows no significant difference between the average values of Qfinger 
discrepancy at baseline and -40mmHg (-1.13 ± 14.67% versus -0.61 ± 9.33%). This 
observation is confirmed by Figures 28 and 29 where blood pressure contour differences 
did not influence Qfinger discrepancy because it is independent of change in TPR and 
variation in Qfin-Qdop discrepancy. This highlights the fact that using finger BP to 
represent aortic BP does not influence the discrepancy in the estimation of Q by 
FinometerTM when a stress is applied. 
Even though brachial BP followed Millar BP more accurately than finger BP (Figures 26 
and 27), the error of Qbrachial was not smaller than the error of Qfinger (Table 8). There 
were actually no significant differences between the average Qfinger discrepancy and 
Qbrachial discrepancy at both baseline and -40mmHg. Moreover, on an individual basis, 
Table 8 shows that in only 50% of the time the error of Qbrachial was smaller than the 
error of Qfinger. Figures 28 and 29 also show that Qbrachial discrepancy varied in the 
same way and almost in the same amount as Qfinger discrepancy during a change in TPR 
(0.42% in comparison to 0.53% for a change of 1mmHg/L/min) and during variation in 
Qfin-Qdop discrepancy (0.12% in comparison to 0.11% for a change of 1%). This allows 
us to conclude that using brachial BP instead of finger BP does not help to solve the 
Qfin-Qdop discrepancy problem. 
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6.3 Limitations 
Here is a list of possible limitations of the project. 
• The first project was a shared study. This means that concessions in the specific 
protocols were made to accommodate the projects of different students. 
• We relied on our subjects to follow the rules of no alcohol or caffeine for twenty-four 
(24) hours prior to the test and concerning the consumption of their breakfast after an 
8h sleep. 
• The neoprene kayak skirt used to seal the LBNP box might have been too tight on the 
waist of the subjects causing compression in the splanchnic area influencing fluid 
distribution. This restriction was not consistent across the different tests. 
• Although only one person was in charge of measuring Q with the Doppler ultrasound 
throughout the project to reduce experimental errors, there was still a possibility that 
the probe was not perfectly oriented toward the root of the aorta at every test. It is 
unknown whether the orientation of the aorta to the direction of the ultrasound beam 
might have been altered during LBNP introducing an error in calculation of Q 
Doppler. 
• Although the pulmonary system is known to buffer imbalances between right 
ventricular and left ventricular output [Rowell, 1993], we assumed that this happened 
only for the few first beats of a stress. We then assumed that EDV was really 
representative of the preload of the heart (CVP) and its time of filling (HR). 
 82 
• Aortic BP is not available in our lab since it required the clinical setting of a hospital. 
We then chose to use brachial BP because it is a good representation of aortic BP. In 
fact, since it is a fairly big artery and it is close to the aorta, it is used as the clinical 
standard for the evaluation of arterial pressure via a sphygmomanometer placed on 
the brachial artery. 
• The applanation tonometry device (Millar) used to monitor aortic BP is not intra-
arterial and therefore it is also subject to error and can account for part of the 
discrepancy between methods. 
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7. Conclusion 
In order to provide scientists and doctors a way to monitor cardiovascular control during 
orthostatic stress, the aim of this project was to develop a simple method with a non-
invasive device: the Finometer
TM
. This kind of method has a lot of potential to provide a 
first evaluation of important clinical signs that might require detailed investigation. Its 
compact design and its non-invasive component are also convenient for research 
involving restricted situations including studies of astronauts or of elderly participants 
who might be uncomfortable consenting to more invasive and intrusive technologies. The 
Finometer
TM
 is already well known and implemented in clinical and research 
laboratories, but it is criticised regarding its accuracy. The first steps of the development 
of this method have been separated in two different projects covering the main questions. 
We first examined whether key variables essential to monitor cardiovascular control can 
be reliably measured and calculated by the Finometer
TM
 in comparison to independent 




We first found that the Finometer
TM
 does have the potential to accurately and precisely be 
used alone to monitor components of cardiovascular control during orthostatic stress. 
Proper use and calibration of the Finometer
TM
 can provide HR, SBP and DBP with 
sufficient accuracy and precision to be valid in most research settings. The primary 
concerns revolve around Q that appears to deviate from its reference, even after a 
calibration, when a stress occurs. 
A major objective of the first hypothesis of this thesis was to examine the accuracy and 
reliability of a non-invasive estimate of CVP. Measurement of CVP requires a catheter 
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but it might be possible to estimate it on the basis of the link with cardiovascular 
function. Overall, the general equations created were not precise enough to be used in 
clinical and research setting, but individual and test equations were more promising. 
Individual equations have proven to be not significantly different than test equations even 
though subjects have been monitored many times over a long period of time. This 
suggests the ability to derive a personal equation that will be useful over a long period for 
similar tests by using a catheter only once. Furthermore, the individual and test equations 
did not improve the result of Gagné and colleagues (2007), but we believe that the fact 
they are using more variables will help to better cover different populations such as 
studies of the elderly. Further tests will be needed to verify this. 
Although a change in TPR induced by LBNP had a direct effect on the pulse contour of 
peripheral arteries compared to the main conduit artery, using finger BP to represent 
aortic BP did not appear to influence the discrepancy in the estimation of Qfin compared 
to Qdop when a stress was applied. Thus, hypotheses 2 and 3 were not supported. It was 
reported that the Langewouters’ estimation causes a small error in the estimation of Q 
[Heermann et al., 2005], therefore since the change in pulse contour did not seem to 
contribute, it appears that the Modelflow equation might then account for a bigger part of 
the error in the estimation of Q and SV during change in TPR than we initially thought. 
Further investigation of the discrepancy between methods could potentially be explored 
by the new contour analysis method introduced here in a graphical format that plotted the 
instantaneous pulse waves by different methods against one another. Systematic analyses 
of the deviation between methods could reveal sources of error allowing identification of 
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Calculation of modelflow model 
The modelflow model is a lumped parameters model represented as an electric circuit 
where the tension is the input BP and the courant is Q: 
 
Figure 30: Electric circuit representing the modelflow model [modified from FMS website] 
It is possible to get the Q waveform from the BP waveform by using the ohm’s equation 
for an electric circuit: izv ⋅=  where v is the tension, z the impedance (resistance) and i is 
the courant. Here is the development I have made from electrical physics equations to 
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And knowing that: 
RL vvv +=  
 and so: eqLLLLR izvizvvvv ⋅−=⋅−=−=  






































































































LR zRz −=  
And presented the conductance component cw to be: dPdAlcw ⋅=  








 Where τ is a time constant. 
The calculation of the aortic diameter (A) is dependent on the pressure and is calculated 
from the Langewouters’ algorithm (eq.2). According to Wesseling and colleagues (1993) 
R is equal to QMAPR /=  and is taken from the previous beat. 










































































Introducing the Wesseling’s equations above into the equation I have made, this is finally 
giving us the following equation to find Q from arterial BP: 
( )





















































































































































































































































































































































































Dependent variables of the relations to calculate CVP 
 
-Equation of EF: 
DBPzEFrestyxEF ⋅+⋅+=  
Table 9: Independent variables of EF equation 
 x y z R
2
 
EF 1.741 * 0.881 0.104 0.964 








baCVP ⋅+⋅+=  
-Equation to calculate CVP with the relation proposed by Gagné and colleagues (2007): 
SVbaCVP ⋅+=  
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Table 10: Independent variables of both relations to calculate CVP 
   New Relation Old Relation 
Subject Test Doppler Finometer Doppler Finometer 
    a b c R
2
 a b c R
2
 a b R
2
 a b R
2
 
A                    
 1 13.406 0.0146 -0.00639 0.939 15.114 0.00482* -0.00743 0.925 -1.042 0.126 0.707 1.088* 0.0888 0.056 
B   10.381 0.05 -0.174 0.407 5.673 0.0492 -0.1 0.295 -0.318* 0.0782 0.383 -1.019 0.0775 0.286 
 1 -17.167 0.146 0.142 0.603 -23.75 0.223 0.0663 0.470 -8.429 0.187 0.592 -19.24 0.29 0.457 
 2 -0.999* 0.0774 -0.0645 0.632 -7.69 0.0881 0.0103* 0.634 -5.625 0.115 0.617 -7.291 0.122 0.623 
C   2.949 0.0421 -0.0855 0.420 5.621 0.0332 -0.113 0.381 -3.402 0.0769 0.402 -4.649 0.0892 0.365 
 1 1.597* 0.0543 -0.0998 0.555 -6.031 0.0799 -0.0392 0.503 -5.718 0.0969 0.506 -9.916 0.128 0.488 
 2 0.501* 0.0411 -0.0247 0.311 -5.281 0.0914 -0.021 0.723 -1.18 0.0573 0.308 -6.94 0.123 0.722 
D   -2.903 0.0882 -0.00463* 0.647 0.149* 0.0958 -0.0958 0.612 -2.956 0.122 0.533 -9.69 0.192 0.482 
 1 -7.161 0.112 0.0439 0.772 -5.735 0.148 -0.0734 0.762 -3.793 0.122 0.772 -14.04 0.233 0.744 
 2 -7.65 0.107 0.0446 0.510 -19.06 0.188 0.0649 0.668 -5.332 0.14 0.518 -14.47 0.234 0.662 
 3 -1.511* 0.0878 -0.038 0.554 1.782* 0.086 -0.112 0.412 -4.306 0.157 0.558 -13.77 0.266 0.638 
E   -3.855 0.0925 -0.024 0.433 -7.986 0.122 -0.0194 0.366 -5.341 0.129 0.412 -8.591 0.162 0.324 
 1 -10.371 0.121 0.0558 0.482 -15.23 0.161 0.0476 0.375 -6.769 0.161 0.479 -11.76 0.213 0.375 
 2 -1.957 0.0866 -0.0629 0.586 -8.718 0.116 -0.0133* 0.517 -6.595 0.132 0.578 -9.519 0.159 0.500 
F   4.142 0.0659 -0.106 0.480 5.127 0.068 -0.125 0.482 -4.443 0.121 0.406 -5.923 0.139 0.354 
 1 9.834 0.0526 -0.141 0.790 -4.016 0.142 -0.0724 0.648 -6.173 0.17 0.425 -13.52 0.274 0.622 
 2 -3.652 0.111 -0.0524 0.772 -5.965 0.138 -0.0616 0.780 -8.687 0.174 0.769 -12.86 0.227 0.761 
 3 -8.57 0.112 -0.0123* 0.749 -2.536 0.108 -0.104 0.736 -9.86 0.203 0.755 -12.25 0.23 0.668 
 4 -8.708 0.11 0.00409* 0.679 -6.145 0.122 -0.0523 0.772 -8.564 0.183 0.684 -12.58 0.241 0.757 
 5 -0.976* 0.121 -0.138 0.592 -11.84 0.198 -0.11 0.724 -13.587 0.195 0.567 -22.35 0.288 0.706 
G   15.015 0.0159 -0.227 0.447 18.032 0.00167* -0.257 0.465 -0.0791* 0.0651 0.279 1.075 0.0467 0.145 
 1 -5.774 0.131 0.012* 0.786 -14.35 0.178 0.1 0.806 -4.99 0.17 0.795 -6.295 0.19 0.781 
 2 -3.801 0.0913 -0.0513 0.795 -4.631 0.102 -0.0735 0.773 -7.844 0.138 0.798 -11.29 0.167 0.767 
H   6.615 0.0668 -0.0967 0.747 10.509 0.043 -0.139 0.611 -0.893 0.137 0.563 -2.127 0.137 0.400 
 1 5.736 0.0611 -0.077 0.656 6.223 0.0622 -0.0979 0.632 -0.417* 0.114 0.615 -3.925 0.153 0.536 
 2 4.15 0.053 -0.000738* 0.404 15.504 -0.0219 -0.0571 0.049 4.087 0.0841 0.405 12.79 -0.034 0.032 
General -0.35 0.0557 0.004 0.297 -0.903 0.0576 0.00254 0.259 0.291 0.0721 0.242 -0.795 0.0794 0.232 
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